Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein receptor found on the cell surface, and its expression is significantly elevated in more than 90% of prostate cancer cells (1000 times more than that in normal prostate cells). Here, FOLH1 is linked to prostate carcinoma.